You are here

Clinical Trials: Myocardial Ischemia

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Thursday, May 16, 2019 - 12:00
Condition:   Coronary Artery Disease
Interventions:   Combination Product: PCI with BioMatrix Alpha™ stent;   Combination Product: PCI with Combo™ stent
Sponsors:   Phillip Freeman;   Aarhus University Hospital;   Odense University Hospital;   OrbusNeich;   Biosensors International
Not yet recruiting
Posted: Wednesday, April 24, 2019 - 12:00
Condition:   Ischemic Heart Disease
Interventions:   Biological: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC);   Other: Placebo
Sponsor:   Rebecca Torguson
Not yet recruiting
Posted: Wednesday, April 3, 2019 - 12:00
Conditions:   Left Ventricular Dysfunction;   Acute Myocardial Infarction
Interventions:   Biological: UC-MSC;   Biological: Control Group
Sponsors:   Shanghai Life Science & Technology;   Shanghai Jiao Tong University Affiliated Sixth People’s Hospital
Not yet recruiting
Posted: Wednesday, January 9, 2019 - 12:00
Condition:   Myocardial Infarction
Interventions:   Combination Product: PeriCord: Expanded and cryopreserved allogeneic umbilical cord Wharton´s jelly-derived adult mesenchymal stem cells colonized on human pericardial matrix.;   Procedure: Surgery by sternotomy
Sponsors:   Fundació Institut Germans Trias i Pujol;   Germans Trias i Pujol Hospital
Not yet recruiting
Posted: Monday, December 3, 2018 - 12:00
Conditions:   Diabetes Mellitus, Type 2;   Coronary Artery Disease
Interventions:   Dietary Supplement: Trans-resveratrol;   Dietary Supplement: Placebo
Sponsors:   Maine Medical Center;   American Heart Association
Recruiting
Posted: Tuesday, November 20, 2018 - 12:00
Condition:   Heart Failure With Reduced Ejection Fraction
Intervention:   Device: VB-C01
Sponsors:   Viscofan;   Ministerio de Ciencia e Innovación, Spain
Recruiting
Posted: Monday, March 12, 2018 - 12:00
Condition:   Acute Myocardial Infarction
Intervention:   Biological: Allogeneic umbilical cord mesenchymal stem cells
Sponsor:   Ever Supreme Bio Technology Co., Ltd.
Not yet recruiting
Posted: Wednesday, March 7, 2018 - 12:00
Conditions:   Refractory Angina;   Chronic Myocardial Ischemia
Interventions:   Device: CardiAMP Cell Therapy System;   Other: Sham Treatment
Sponsor:   BioCardia, Inc.
Not yet recruiting
Posted: Friday, January 19, 2018 - 12:00
Condition:   Myocardial Infarction
Interventions:   Drug: Cardiac Drug;   Drug: Placebos
Sponsors:   John Paul II Hospital, Krakow;   KCRI;   National Center for Research and Development, Poland
Recruiting
Posted: Thursday, January 11, 2018 - 12:00
Condition:   Ischemic Heart Disease
Interventions:   Combination Product: CSWT+BMMSCs;   Device: CSWT+Sham operation
Sponsor:   Shanghai 10th People's Hospital
Recruiting

Pages